Roche RHHBY today announced that it filed its
definitive proxy statement and sent a letter to shareholders of Illumina
ILMN urging them to tender their shares into Roche's offer and vote
for Roche's independent director nominees and other proposals at the 2012
Illumina annual meeting to be held on 18 April 2012.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in